Table 3.
Exploratory analyses: community sample (17 items) | Confirmatory analysis: clinical trials, one-factor solution (10 items) | |||||
---|---|---|---|---|---|---|
One-factor solution (n = 141) | Two-factor solution (n = 141) | BTH yoga study (n = 55) | MAP study (n = 41) | POYSE study (n = 85) | ||
Total % variance explained | 0.62 | 0.71 | Total % variance explained | 0.61 | 0.65 | 0.74 |
Chi-square | 926.7 | 527.8 | SRMSR | 0.07 | 0.05 | 0.05 |
Chi-square df | 119 | 103 | ML chi-square | 124.9 | 57.0 | 141.2 |
p-Value | <0.001 | <0.001 | Chi-square df | 35 | 35 | 35 |
RMSEA (90% CI) | 0.23 (0.21–0.23) | 0.18 (0.16–0.19) | ML chi-square p-value | <0.001 | 0.01 | <0.001 |
RMSR | 0.10 | 0.05 | ML RMSEA (90% CI) | 0.22 (0.18–0.26) | 0.12 (0.06–0.18) | 0.19 (0.16–0.22) |
TLI | 0.65 | 0.79 | ML TLI | 0.75 | 0.92 | 0.86 |
BIC | 337.8 | 18.1 | ML CFI | 0.81 | 0.94 | 0.89 |
Robust chi-square | 54.36 | 49.90 | 80.18 | |||
Robust chi-square p-value | 0.02 | 0.049 | <0.001 | |||
Robust RMSEA (90% CI) | 0.10 (0.06–0.13) | 0.10 (0.02–0.16) | 0.12 (0.10–0.15) | |||
Robust TLI | 0.93 | 0.87 | 0.92 | |||
Robust CFI | 0.94 | 0.90 | 0.94 |
CFI = comparative fit index;
CI = confidence interval;
df = degrees of freedom;
ML = maximum likelihood;
RMSEA = root mean square error of approximation;
SRMSR = standardized root mean square residual;
TLI = Tucker–Lewis index.